DAWN sheds new light on psychological insulin resistance Meeting report 10 February 2013 Pages: 3 - 4
Doxorubicin liposomal cost saving vs topotecan in ovarian cancer Clinical study 10 February 2013 Pages: 5 - 5
Flawed model assumptions incorrectly favour more costly drugs Media release 10 February 2013 Pages: 6 - 6
Off-label antibacterial prescribing common among paediatrics Clinical study 10 February 2013 Pages: 6 - 6
Antisecretory use continues after H. pylori eradication in Denmark Clinical study 10 February 2013 Pages: 7 - 7
Depression and alcoholism more costly than depression alone Clinical study 10 February 2013 Pages: 7 - 7
Hylan-G-F-20 warranted for knee osteoarthritis in France Clinical study 10 February 2013 Pages: 7 - 7
Lower healthcare costs offset longevity in healthy US elderly Clinical study 10 February 2013 Pages: 8 - 8
VTE prophylaxis rarely prescribed by oncologists in England Clinical study 10 February 2013 Pages: 8 - 8
Metformin, lifestyle interventions worth it for diabetes prevention News item 10 February 2013 Pages: 9 - 9
Nosocomial bloodstream infections generate high costs in the US Clinical study 10 February 2013 Pages: 9 - 9
Gemcitabine + vinorelbine less toxic but no QOL advantage Clinical study 10 February 2013 Pages: 10 - 10
QOL effect of treatment duration with vitamin K antagonists Clinical study 10 February 2013 Pages: 10 - 10
Access to HIV/AIDS drugs expanded in Africa, Brazil, Indonesia News item 10 February 2013 Pages: 11 - 11
Osteoporosis market to reach $US14 billion over next 8 years News item 10 February 2013 Pages: 11 - 11